Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01259427 · ClinicalTrials.gov registry record · Phase 2
Reducing Internalized Stigma in People With Serious Mental Illness
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 252
- Enrollment target
NCT01259427: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT01259427 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 252 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01259427, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 252 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Ending Self-Stigma (ESS), a 9-session group intervention designed to assist veterans with serious mental illness to develop skills (SMI) to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes, is more effective in reducing internalized stigma and its associated effects than an active comparison group.
Interventions
- BEHAVIORAL Ending Self Stigma (ESS)
- BEHAVIORAL Health and Wellness Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01259427
The ClinicalTrials.gov registry entry for NCT01259427 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ending Self Stigma (ESS) is the first listed.
NCT01259427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01259427 about?
NCT01259427 is a clinical study titled "Reducing Internalized Stigma in People With Serious Mental Illness". The purpose of this study is to determine if Ending Self-Stigma (ESS), a 9-session group intervention designed to assist veterans with serious mental illness to develop skills (SMI) to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes, is more effe...
What is the current status of trial NCT01259427?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 252 participants. The study started on 2011-10. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01259427?
The interventions under investigation include: Ending Self Stigma (ESS) (BEHAVIORAL), Health and Wellness Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01259427?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.